Annual SG&A
$38.89 M
+$1.32 M+3.52%
31 December 2023
Summary:
Core Laboratories NV annual selling, general & administrative expenses is currently $38.89 million, with the most recent change of +$1.32 million (+3.52%) on 31 December 2023. During the last 3 years, it has risen by +$4.86 million (+14.28%). CLB annual SG&A is now -38.18% below its all-time high of $62.91 million, reached on 31 December 2018.CLB Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$8.33 M
-$1.93 M-18.82%
30 September 2024
Summary:
Core Laboratories NV quarterly selling, general & administrative expenses is currently $8.33 million, with the most recent change of -$1.93 million (-18.82%) on 30 September 2024. Over the past year, it has dropped by -$788.00 thousand (-8.64%). CLB quarterly SG&A is now -66.31% below its all-time high of $24.72 million, reached on 31 December 2018.CLB Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
$519.68 M
+$24.32 M+4.91%
30 September 2024
Summary:
Core Laboratories NV TTM selling, general & administrative expenses is currently $519.68 million, with the most recent change of +$24.32 million (+4.91%) on 30 September 2024. Over the past year, it has increased by +$480.15 million (+1214.75%). CLB TTM SG&A is now -75.64% below its all-time high of $67.64 million, reached on 31 March 2019.CLB TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLB Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.5% | -8.6% | +1214.8% |
| 3 y3 years | +14.3% | -44.9% | +1658.4% |
| 5 y5 years | -38.2% | -24.4% | +729.7% |
CLB Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -11.3% | +14.3% | -48.0% | +43.3% | at high | +116.2% |
| 5 y | 5 years | -38.2% | +14.3% | -57.4% | +325.6% | -23.9% | +217.5% |
| alltime | all time | -38.2% | +1340.5% | -66.3% | +325.6% | -75.6% | >+9999.0% |
Core Laboratories NV Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $8.33 M(-18.8%) | $38.38 M(-2.0%) |
| June 2024 | - | $10.26 M(-10.8%) | $39.17 M(+12.8%) |
| Mar 2024 | - | $11.50 M(+38.7%) | $34.72 M(-11.5%) |
| Dec 2023 | $38.89 M(+3.5%) | $8.29 M(-9.0%) | $39.22 M(-0.8%) |
| Sept 2023 | - | $9.12 M(+56.9%) | $39.53 M(-1.9%) |
| June 2023 | - | $5.81 M(-63.7%) | $40.28 M(-2.2%) |
| Mar 2023 | - | $16.00 M(+86.2%) | $41.18 M(+0.3%) |
| Dec 2022 | $37.57 M(-14.4%) | $8.60 M(-12.9%) | $41.05 M(-4.7%) |
| Sept 2022 | - | $9.87 M(+47.1%) | $43.08 M(-10.9%) |
| June 2022 | - | $6.71 M(-57.7%) | $48.32 M(-5.8%) |
| Mar 2022 | - | $15.88 M(+49.5%) | $51.28 M(+16.9%) |
| Dec 2021 | $43.87 M(+28.9%) | $10.62 M(-29.7%) | $43.87 M(+48.4%) |
| Sept 2021 | - | $15.12 M(+56.3%) | $29.55 M(+26.4%) |
| June 2021 | - | $9.67 M(+14.3%) | $23.38 M(+2.0%) |
| Mar 2021 | - | $8.46 M(-329.2%) | $22.93 M(-32.6%) |
| Dec 2020 | $34.03 M(-29.1%) | -$3.69 M(-141.3%) | $34.03 M(-28.3%) |
| Sept 2020 | - | $8.94 M(-3.1%) | $47.50 M(-4.2%) |
| June 2020 | - | $9.22 M(-52.9%) | $49.57 M(-0.5%) |
| Mar 2020 | - | $19.57 M(+100.2%) | $49.82 M(+4.5%) |
| Dec 2019 | $48.02 M(-23.7%) | $9.77 M(-11.3%) | $47.69 M(-23.9%) |
| Sept 2019 | - | $11.01 M(+16.3%) | $62.64 M(-3.5%) |
| June 2019 | - | $9.47 M(-45.7%) | $64.90 M(-4.0%) |
| Mar 2019 | - | $17.44 M(-29.5%) | $67.64 M(+7.5%) |
| Dec 2018 | $62.91 M(+31.8%) | $24.72 M(+86.2%) | $62.91 M(+25.4%) |
| Sept 2018 | - | $13.28 M(+8.8%) | $50.18 M(+2.9%) |
| June 2018 | - | $12.20 M(-4.0%) | $48.79 M(+2.3%) |
| Mar 2018 | - | $12.71 M(+6.0%) | $47.69 M(-0.1%) |
| Dec 2017 | $47.74 M(+21.2%) | $11.99 M(+0.9%) | $47.74 M(+7.2%) |
| Sept 2017 | - | $11.89 M(+7.1%) | $44.54 M(+8.5%) |
| June 2017 | - | $11.10 M(-13.0%) | $41.06 M(-0.1%) |
| Mar 2017 | - | $12.76 M(+45.0%) | $41.10 M(+4.3%) |
| Dec 2016 | $39.39 M(-20.8%) | $8.79 M(+4.6%) | $39.39 M(-8.1%) |
| Sept 2016 | - | $8.41 M(-24.5%) | $42.86 M(-8.0%) |
| June 2016 | - | $11.14 M(+0.8%) | $46.61 M(-3.1%) |
| Mar 2016 | - | $11.05 M(-9.9%) | $48.10 M(-3.3%) |
| Dec 2015 | $49.73 M(+8.9%) | $12.27 M(+0.9%) | $49.73 M(+1.2%) |
| Sept 2015 | - | $12.15 M(-3.8%) | $49.13 M(-0.3%) |
| June 2015 | - | $12.63 M(-0.3%) | $49.30 M(+3.1%) |
| Mar 2015 | - | $12.67 M(+8.6%) | $47.81 M(+4.7%) |
| Dec 2014 | $45.66 M(-12.2%) | $11.67 M(-5.2%) | $45.66 M(-4.2%) |
| Sept 2014 | - | $12.32 M(+10.5%) | $47.64 M(-4.1%) |
| June 2014 | - | $11.15 M(+6.0%) | $49.67 M(-0.1%) |
| Mar 2014 | - | $10.52 M(-23.0%) | $49.70 M(-4.4%) |
| Dec 2013 | $51.99 M(+20.4%) | $13.66 M(-4.8%) | $51.99 M(+2.7%) |
| Sept 2013 | - | $14.35 M(+28.4%) | $50.63 M(+8.2%) |
| June 2013 | - | $11.17 M(-12.8%) | $46.79 M(+2.1%) |
| Mar 2013 | - | $12.81 M(+4.1%) | $45.82 M(+6.1%) |
| Dec 2012 | $43.19 M(+5.0%) | $12.30 M(+17.1%) | $43.19 M(+5.7%) |
| Sept 2012 | - | $10.50 M(+2.9%) | $40.85 M(-1.6%) |
| June 2012 | - | $10.21 M(+0.3%) | $41.53 M(+1.1%) |
| Mar 2012 | - | $10.17 M(+2.1%) | $41.08 M(+1.6%) |
| Dec 2011 | $41.14 M(+24.6%) | $9.97 M(-10.9%) | $40.43 M(+2.4%) |
| Sept 2011 | - | $11.18 M(+14.6%) | $39.48 M(+7.5%) |
| June 2011 | - | $9.76 M(+2.4%) | $36.72 M(+1.5%) |
| Mar 2011 | - | $9.52 M(+5.6%) | $36.17 M(+9.5%) |
| Dec 2010 | $33.03 M | $9.02 M(+7.2%) | $33.03 M(+3.9%) |
| Sept 2010 | - | $8.42 M(-8.6%) | $31.78 M(+5.9%) |
| June 2010 | - | $9.21 M(+44.4%) | $30.00 M(+9.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2010 | - | $6.38 M(-18.0%) | $27.48 M(-9.5%) |
| Dec 2009 | $30.37 M(-4.0%) | $7.78 M(+17.2%) | $30.37 M(-4.9%) |
| Sept 2009 | - | $6.64 M(-0.7%) | $31.94 M(-0.7%) |
| June 2009 | - | $6.68 M(-27.9%) | $32.16 M(-1.5%) |
| Mar 2009 | - | $9.27 M(-0.7%) | $32.63 M(+3.1%) |
| Dec 2008 | $31.65 M(-6.5%) | $9.34 M(+36.2%) | $31.65 M(+1.0%) |
| Sept 2008 | - | $6.86 M(-4.2%) | $31.34 M(-0.6%) |
| June 2008 | - | $7.16 M(-13.6%) | $31.53 M(-7.5%) |
| Mar 2008 | - | $8.29 M(-8.3%) | $34.09 M(+0.7%) |
| Dec 2007 | $33.84 M(+2.3%) | $9.04 M(+28.4%) | $33.84 M(+4.4%) |
| Sept 2007 | - | $7.04 M(-27.6%) | $32.42 M(+2.5%) |
| June 2007 | - | $9.72 M(+20.9%) | $31.63 M(+3.5%) |
| Mar 2007 | - | $8.04 M(+5.4%) | $30.58 M(-7.6%) |
| Dec 2006 | $33.08 M(-12.6%) | $7.62 M(+22.0%) | $33.08 M(-10.9%) |
| Sept 2006 | - | $6.25 M(-27.9%) | $37.12 M(-11.1%) |
| June 2006 | - | $8.66 M(-17.8%) | $41.75 M(+2.5%) |
| Mar 2006 | - | $10.54 M(-9.6%) | $40.73 M(+7.6%) |
| Dec 2005 | $37.85 M(+34.5%) | $11.67 M(+7.3%) | $37.85 M(+16.1%) |
| Sept 2005 | - | $10.87 M(+42.2%) | $32.61 M(+16.4%) |
| June 2005 | - | $7.65 M(-0.2%) | $28.02 M(-5.3%) |
| Mar 2005 | - | $7.66 M(+19.1%) | $29.59 M(+5.2%) |
| Dec 2004 | $28.14 M(+23.5%) | $6.43 M(+2.3%) | $28.14 M(-0.8%) |
| Sept 2004 | - | $6.29 M(-31.8%) | $28.36 M(+2.6%) |
| June 2004 | - | $9.22 M(+48.5%) | $27.65 M(+18.0%) |
| Mar 2004 | - | $6.21 M(-6.7%) | $23.43 M(+2.8%) |
| Dec 2003 | $22.79 M(+12.9%) | $6.65 M(+19.3%) | $22.79 M(+5.8%) |
| Sept 2003 | - | $5.58 M(+11.7%) | $21.54 M(+3.0%) |
| June 2003 | - | $4.99 M(-10.4%) | $20.91 M(+0.1%) |
| Mar 2003 | - | $5.57 M(+3.0%) | $20.89 M(+4.5%) |
| Dec 2002 | $20.18 M(+26.7%) | $5.41 M(+9.4%) | $19.99 M(+6.8%) |
| Sept 2002 | - | $4.94 M(-0.7%) | $18.71 M(+3.8%) |
| June 2002 | - | $4.98 M(+6.7%) | $18.03 M(+5.8%) |
| Mar 2002 | - | $4.67 M(+13.1%) | $17.03 M(+6.9%) |
| Dec 2001 | $15.93 M(+17.6%) | $4.13 M(-3.1%) | $15.93 M(+4.7%) |
| Sept 2001 | - | $4.26 M(+6.9%) | $15.21 M(+5.7%) |
| June 2001 | - | $3.98 M(+11.9%) | $14.40 M(+4.4%) |
| Mar 2001 | - | $3.56 M(+4.3%) | $13.80 M(+1.9%) |
| Dec 2000 | $13.54 M(+10.1%) | $3.41 M(-0.8%) | $13.54 M(-1.4%) |
| Sept 2000 | - | $3.44 M(+1.7%) | $13.73 M(+3.3%) |
| June 2000 | - | $3.38 M(+2.4%) | $13.29 M(+3.3%) |
| Mar 2000 | - | $3.30 M(-8.3%) | $12.87 M(+4.5%) |
| Dec 1999 | $12.30 M(+45.6%) | $3.60 M(+20.0%) | $12.31 M(+12.4%) |
| Sept 1999 | - | $3.00 M(+1.2%) | $10.96 M(+6.8%) |
| June 1999 | - | $2.96 M(+7.9%) | $10.26 M(+10.4%) |
| Mar 1999 | - | $2.75 M(+22.3%) | $9.29 M(+10.0%) |
| Dec 1998 | $8.45 M(+40.8%) | $2.25 M(-2.3%) | $8.45 M(+8.3%) |
| Sept 1998 | - | $2.30 M(+15.0%) | $7.80 M(+5.4%) |
| June 1998 | - | $2.00 M(+5.3%) | $7.40 M(+8.8%) |
| Mar 1998 | - | $1.90 M(+18.8%) | $6.80 M(+15.3%) |
| Dec 1997 | $6.00 M(+66.7%) | $1.60 M(-15.8%) | $5.90 M(+13.5%) |
| Sept 1997 | - | $1.90 M(+35.7%) | $5.20 M(+26.8%) |
| June 1997 | - | $1.40 M(+40.0%) | $4.10 M(+13.9%) |
| Mar 1997 | - | $1.00 M(+11.1%) | $3.60 M(+2.9%) |
| Dec 1996 | $3.60 M(+33.3%) | $900.00 K(+12.5%) | $3.50 M(+6.1%) |
| Sept 1996 | - | $800.00 K(-11.1%) | $3.30 M(0.0%) |
| June 1996 | - | $900.00 K(0.0%) | $3.30 M(+37.5%) |
| Mar 1996 | - | $900.00 K(+28.6%) | $2.40 M(+60.0%) |
| Dec 1995 | $2.70 M | $700.00 K(-12.5%) | $1.50 M(+87.5%) |
| Sept 1995 | - | $800.00 K | $800.00 K |
FAQ
- What is Core Laboratories NV annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Core Laboratories NV?
- What is Core Laboratories NV annual SG&A year-on-year change?
- What is Core Laboratories NV quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Core Laboratories NV?
- What is Core Laboratories NV quarterly SG&A year-on-year change?
- What is Core Laboratories NV TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Core Laboratories NV?
- What is Core Laboratories NV TTM SG&A year-on-year change?
What is Core Laboratories NV annual selling, general & administrative expenses?
The current annual SG&A of CLB is $38.89 M
What is the all time high annual SG&A for Core Laboratories NV?
Core Laboratories NV all-time high annual selling, general & administrative expenses is $62.91 M
What is Core Laboratories NV annual SG&A year-on-year change?
Over the past year, CLB annual selling, general & administrative expenses has changed by +$1.32 M (+3.52%)
What is Core Laboratories NV quarterly selling, general & administrative expenses?
The current quarterly SG&A of CLB is $8.33 M
What is the all time high quarterly SG&A for Core Laboratories NV?
Core Laboratories NV all-time high quarterly selling, general & administrative expenses is $24.72 M
What is Core Laboratories NV quarterly SG&A year-on-year change?
Over the past year, CLB quarterly selling, general & administrative expenses has changed by -$788.00 K (-8.64%)
What is Core Laboratories NV TTM selling, general & administrative expenses?
The current TTM SG&A of CLB is $519.68 M
What is the all time high TTM SG&A for Core Laboratories NV?
Core Laboratories NV all-time high TTM selling, general & administrative expenses is $67.64 M
What is Core Laboratories NV TTM SG&A year-on-year change?
Over the past year, CLB TTM selling, general & administrative expenses has changed by +$480.15 M (+1214.75%)